Regional angiogenesis with vascular endothelial growth factor (VEGF) in peripheral arterial disease: Design of the RAVE trial
- 30 June 2003
- journal article
- clinical trial
- Published by Elsevier BV in American Heart Journal
- Vol. 145 (6), 1114-1118
- https://doi.org/10.1016/s0002-8703(03)00102-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trialThe Lancet, 2002
- Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2Circulation, 2002
- Myocardial gene therapyNature, 2002
- Clinical Trials in Coronary Angiogenesis: Issues, Problems, ConsensusCirculation, 2000
- Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularizationJCI Insight, 1999
- Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusionJournal of Vascular Surgery, 1998
- Regional Angiogenesis Induced in Nonischemic Tissue by an Adenoviral Vector Expressing Vascular Endothelial Growth FactorHuman Gene Therapy, 1997
- Clinical Trials for ClaudicationCirculation, 1995
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.JCI Insight, 1994
- Benefit of exercise conditioning for patients with peripheral arterial disease.Circulation, 1990